Study details
Enrolling now
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Cedars-Sinai Medical Center
NCT IDNCT07124351ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
15
Study length
about 1.1 years
Ages
18+
Locations
1 site in CA
What this study is about
Researchers are testing a treatment called CYTALUX™ (pafolacianine) to see if it can help detect gastrointestinal cancers during surgery. The trial will last for 390 days and involve adults.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CYTALUX™ (pafolacianine)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
pafolacianine
Endpoints
Primary: Feasibility of CYTALUX™ (pafolacianine) with near-infrared (NIR) fluorescent imaging
Body systems
Oncology